Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Cell Communication and Signaling : CCS
|
March 14, 2023
Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells
Mingming Wu, Xiao Zhang, Weijie Zhang, et al.
Frontiers in Bioengineering and Biotechnology
|
November 17, 2022
The single-atom iron nanozyme mimicking peroxidase remodels energy metabolism and tumor immune landscape for synergistic chemodynamic therapy and photothermal therapy of triple-negative breast cancer
Xiaojun Qian, Ronghua Shi, Jian Chen, et al.
Oxidative Medicine and Cellular Longevity
|
February 18, 2022
Unraveling the Expression Patterns of Immune Checkpoints Identifies New Subtypes and Emerging Therapeutic Indicators in Lung Adenocarcinoma
Jinguo Zhang, Xinghua Han, Lin Lin, et al.
Cancer Research
|
February 9, 2024
Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion
Linlin Yan, Mingming Wu, Tianyu Wang, et al.
International Journal of Biological Sciences
|
January 29, 2026
The Interaction of <i>CircESR1</i> and HNRNPAB Regulates Cell Cycle Transition of Breast Cancer Cell
Junchao Xu, Qiao Xu, Tingfang Cao, et al.
Oncogene
|
February 28, 2024
LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance
Leiyan Yang, Miaomiao Wang, Ya Wang, et al.
International Journal of Molecular Sciences
|
June 10, 2023
LncRNA <i>H19</i> Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2
Junsong Zhao, Junchao Xu, Mingming Wu, et al.
Investigational New Drugs
|
October 27, 2023
Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1-3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trial
Ting Deng, Le Zhang, Yehui Shi, et al.
Oncogene
|
February 14, 2026
BRD4 orchestrates the metabolic-epigenetic regulation of GM-CSF expression and secretion to drive PD-L1⁺ macrophage-mediated immune evasion in triple-negative breast cancer
Haizhou Diao, Jingxiong Chen, Yan Zhang, et al.
Journal for Immunotherapy of Cancer
|
June 3, 2026
Igniting cold tumors: reprogramming the tumor immune microenvironment with dual-payload ADCs in combination with PD-L1&4-1BB bispecific antibodies
Jing Pan, Xiaolong Yuan, Haiyang Yu, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Cell Communication and Signaling : CCS
|
March 14, 2023
Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells
Mingming Wu, Xiao Zhang, Weijie Zhang, et al.
Frontiers in Bioengineering and Biotechnology
|
November 17, 2022
The single-atom iron nanozyme mimicking peroxidase remodels energy metabolism and tumor immune landscape for synergistic chemodynamic therapy and photothermal therapy of triple-negative breast cancer
Xiaojun Qian, Ronghua Shi, Jian Chen, et al.
Oxidative Medicine and Cellular Longevity
|
February 18, 2022
Unraveling the Expression Patterns of Immune Checkpoints Identifies New Subtypes and Emerging Therapeutic Indicators in Lung Adenocarcinoma
Jinguo Zhang, Xinghua Han, Lin Lin, et al.
Cancer Research
|
February 9, 2024
Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion
Linlin Yan, Mingming Wu, Tianyu Wang, et al.
International Journal of Biological Sciences
|
January 29, 2026
The Interaction of <i>CircESR1</i> and HNRNPAB Regulates Cell Cycle Transition of Breast Cancer Cell
Junchao Xu, Qiao Xu, Tingfang Cao, et al.
Oncogene
|
February 28, 2024
LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance
Leiyan Yang, Miaomiao Wang, Ya Wang, et al.
International Journal of Molecular Sciences
|
June 10, 2023
LncRNA <i>H19</i> Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2
Junsong Zhao, Junchao Xu, Mingming Wu, et al.
Investigational New Drugs
|
October 27, 2023
Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1-3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trial
Ting Deng, Le Zhang, Yehui Shi, et al.
Oncogene
|
February 14, 2026
BRD4 orchestrates the metabolic-epigenetic regulation of GM-CSF expression and secretion to drive PD-L1⁺ macrophage-mediated immune evasion in triple-negative breast cancer
Haizhou Diao, Jingxiong Chen, Yan Zhang, et al.
Journal for Immunotherapy of Cancer
|
June 3, 2026
Igniting cold tumors: reprogramming the tumor immune microenvironment with dual-payload ADCs in combination with PD-L1&4-1BB bispecific antibodies
Jing Pan, Xiaolong Yuan, Haiyang Yu, et al.
Page
of 7